GDUFA Grace Period For Facility Fees Appears To Be Over
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s drastically expanded arrears list for FY 2014 fees totals more than 100 generic drug facilities; more than 40 still owe the FY 2013 fee.